메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer's Association, and CurePSP Join Forces to Award $2.5 Million in Neurodegenerative Disease Research Grants from 2025 Tauopathy Challenge Workshop

Established in 2023, the Tauopathy Challenge Workshop aims to bridge the gap in funding of novel neurodegenerative research for primary tauopathies, including Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Frontotemporal Dementias (FTDs). FORT WORTH, Texas, Aug. 13, 2025 -- The Rainwater Charitable Foundation, one of the largest independent funders of primary tauopathy research, in collaboration with the Aging Mind Foundation, the Alzheimer's Association, and CurePSP, announced today $2.5 million in grants to fund five innovative research projects ov
- 김갑성 기자
- 2025-08-13 20:00
BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan

- BioDlink's bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria, marking key regulatory milestones in high-need emerging markets. - GMP certification in Brazil, Colombia, and Argentina spans the top three most populous countries in South America, collectively representing 71.4% of the continent's population. - Backed by a globally recognized quality system and a strong track record in monoclonal antibody, ADC/XDC, biosimilar development and manufacturing, BioDlink, in partnership with Kexing BioPharm is
- 김갑성 기자
- 2025-08-13 20:00
New Study Demonstrates Superiority of EggNest™ Complete Radiation Protection System in Comprehensive Protection for the Entire Interventional Team

MINNEAPOLIS, Aug. 13, 2025 -- A recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlights the effectiveness of the EggNest™ Complete radiation shielding system, demonstrating its superior ability to protect all personnel in the catheterization lab from scatter radiation. The findings show that while other next-generation systems offer protection for the primary operator and assistant, the EggNest™ Complete system provides significant protection for the entire interventional team. The study, titled "Co
- 김갑성 기자
- 2025-08-13 19:30
Pioneering Freeze-Dried Technology in Vietnam: Nature Foods Company Introduces Convenient and Healthy Eating Solutions

HO CHI MINH CITY, Vietnam, Aug. 13, 2025 -- Amid rapid urbanization and an increasingly fast-paced lifestyle, Vietnam's ready-to-eat (RTE) food market is witnessing remarkable growth. In 2024, the market value reached approximately USD 430 million and is projected to nearly triple to USD 1.28 billion by 2031, with a compound annual growth rate (CAGR) of 16.8% (BlueWeave Consulting). This surge underscores a clear consumer trend: the demand for quick meal solutions that still meet high standards of nutrition, quality, and safety. Yet, convenience alone is not enough. Flavor, nutrition,
- 김갑성 기자
- 2025-08-13 16:41
Avive Health to host Queensland's first Empax clinic in landmark mental health partnership with Emyria

BRISBANE, Australia, Aug. 13, 2025 -- Avive Health ("Avive"), an Australian-owned private mental health provider, has announced a major national partnership with Emyria Limited (ASX: EMD), marking a significant milestone in the evolution of evidence-based, reimbursable mental health treatment across Australia. Avive delivers inpatient, day program and outpatient psychiatric care across Australia's eastern seaboard, with a strong focus on trauma-informed, patient-centred models that combine clinical rigor with therapeutic innovation. The organisation supports voluntary adult patients th
- 김갑성 기자
- 2025-08-13 15:40
Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new global benchmark A potential game changer that addresses both the pain of injections and the low efficiency of oral formulations In the obesity treatment market, delivery technology is expected to be the decisive factor shaping future leaders SEOUL, South Korea, Aug. 13, 2025 -- Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) and Daewoong Therapeutics (CEO Bok-Ki Kang) announced that t
- 김갑성 기자
- 2025-08-13 15:36
Hospital Management Asia 2025: Shaping the Future of Asian Healthcare

HO CHI MINH CITY, Vietnam, Aug. 13, 2025 -- Hospital Management Asia (HMA), the region's premier annual event for hospital management and healthcare, is set to officially take place at GEM Center, Ho Chi Minh City. This year's conference, organised by Clarion Events Pte Ltd, will gather over 100 speakers from 15 countries and territories, alongside hundreds of hospital leaders, medical professionals, and healthcare organizations from across the region and beyond. From Healthcare System Reform to Medical Tourism Under the theme "Quality, Experience & Leadership i
- 김갑성 기자
- 2025-08-13 15:19
Prince Court Medical Centre Strengthens Malaysia's Position as a Global Healthcare Destination with First Kelly Procedure

KUALA LUMPUR, Malaysia, Aug. 13, 2025 -- Prince Court Medical Centre has placed Malaysia firmly on the global medical tourism map by successfully performing the country's first Kelly procedure, an advanced reconstructive surgery for rare congenital urological conditions. On 11 August, a two-year-old boy from Indonesia underwent the pioneering surgery, jointly led by Dr. Roger Anthony Idi, Consultant Urologist at Prince Court, and Professor Imran Mushtaq, a world-renowned paediatric urologist recognised internationally for his expertise in complex reconstructive surgery for rare
- 김갑성 기자
- 2025-08-13 15:16
정밀 의료, 한국에서 60조원의 경제 효과 및 치료 패러다임 전환 예고

[ 메디채널 김갑성 기자 ] 정밀 의료 접근성 향상 위해 규제 및 시스템적 개선 필요 서울, 대한민국, 2025년 8월 13일 -- 글로벌 전략 컨설팅 기업 'L.E.K. 컨설팅'이 오늘 발표한 백서 '정밀 의료 사례 연구 보고서(On the Cusp of a Cure)'에 따르면, 정밀 의료 시대가 본격화되면 향후 10년간 한국에서 약 60조 원의 경제 효과와 보건의료 전반에 걸친 사회•경제적 가치가 실현될 것으로 전망된다. 정밀 의료는 기존의 획일적인 치료 방식과 달리 환자 개개인의 유전적 정보와 질병 특성에 기반해 맞춤형 치료를 제공하는 새로운 접근 방식으로, 질환에 대해 근본적인 치료 가능성을 제시한다. 유전자 치료제, 표적 항체 치료제, 약물-기기 복합 치료제, 정밀 진단 기술이 정밀 의료의 대표적인 핵심 기술이다. 이번 보고서는 글로벌 컨설팅 회사 L.E.K. 컨설팅과 아시아태평양 지역 16인의 전문가 자문위원회가 함께 개발한 것으로, '전체 시스템 이익 모델링(whole system benefits modelling)'을 활용해 한국에서 정밀 의료가 가져올 경제 및 보건의료적 효과를 분석했다.
- 김갑성 기자
- 2025-08-13 10:51
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration

SINGAPORE, Aug. 13, 2025 -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr. Huang"), in support of arbitration proceedings respectively commenced by the Company and by Novo Nordisk A/S ("Novo Nordisk"). Following the Court's judgment today, the validity of the injunction application sought by Novo Nordisk will be determined via the arbitral
- 김갑성 기자
- 2025-08-13 09:44

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 05일 13시 00분